Presentation ESC 2025 SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease Presenter: Mårten Falkenberg, Joakim Nordanstig August 31, 2025
Presentation ESC 2024 Optical coherence tomography-guided coronary intervention in patients with complex lesions: The OCCUPI Randomized Clinical Trial Presenter: Byeong-Keuk Kim September 02, 2024
Presentation ESC 2024 INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population Presenter: David Erlinge September 02, 2024
Presentation ESC 2024 DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial Presenter: Ling Tao September 02, 2024
Presentation ESC 2024 The ASSURE DES Randomized Clinical Trial Presenter: Jung-Min Ahn August 31, 2024
Presentation ESC 2018 Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2 Presenter: Raban V. Jeger August 31, 2018
Presentation ESC 2018 Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium Presenter: Holger M. Nef August 29, 2018
Presentation ESC 2018 ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Presenter: Robert Byrne August 29, 2018
Presentation ESC 2018 The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Presenter: Marco Valgimigli August 26, 2018
Presentation ESC 2017 BIOFLOW V Comparison of Ultrathin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus-Eluting Durable Polymer Stents Presenter: David E Kandzari September 13, 2017
Presentation ESC 2017 Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation Presenter: Borja Ibanez August 28, 2017
Presentation ESC 2017 Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial Presenter: David Erlinge August 27, 2017
Presentation ESC 2016 Drug-Eluting vs Bare Metal Stents in Saphenous Vein Grafts: The Prospective Randomized BASKET-SAVAGE Trial Presenter: Raban V. Jeger August 31, 2016
Presentation ESC 2016 NIPPON Randomized Study: 6 Months vs 18 Months Dual Antiplatelet Treatment For Patients Underwent Bioabsorbable Polymer And Abluminal Coated DES Deployment Presenter: Masato Nakamura August 28, 2016
Presentation ESC 2015 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions Presenter: Takeshi Kimura September 01, 2015
Presentation ESC 2015 12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial Presenter: G?rard Helft August 31, 2015
Presentation ESC 2014 Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization Presenter: Thomas Pilgrim September 01, 2014
Presentation ESC 2014 SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents Presenter: Christoph Varenhorst August 30, 2014
Presentation ESC 2012 Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial Presenter: William Wijns August 27, 2012